Current sickle cell disease (SCD) trial eligibility criteria exclude most adults, with only 9.9% meeting inclusion thresholds ...
Historically characterized by excessive daytime sleepiness and cataplexy, narcolepsy is increasingly recognized as a ...
Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...
First, the AASM guideline recommends a combination of CBT‑I and medication over medication alone for adults with chronic ...
Anita Kumar, MD, of Memorial Sloan Kettering Cancer Center details evolving mantle cell lymphoma care: ECHO acalabrutinib-BR and chemo-free zanubrutinib BOVen triplets challenge standards.
Baseline QOL is an independent prognostic factor for survival in AML, with global QOL carrying the largest HR, according to ...
Phase 1 BALLI-01 trial results showed promising UCART22 activity in R/R B-cell ALL, with higher remission rates after a ...
State data reveal 2026 ACA marketplace enrollment losses are accelerating post open enrollment, as cancellations surge and ...
Standardized order sets, clinical team training on toxicity grading and treatment algorithms, and immediate access to ...
This analysis compared health care resource utilization and costs for Medicaid patients with serious mental illness between ...
After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...
Alexander Spira, MD, PhD, medical oncologist at Virginia Cancer Specialists and chief scientific officer of NEXT Oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results